| Title |
The benefits and risks of testosterone replacement therapy: a review
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, June 2009
|
| DOI | 10.2147/tcrm.s3025 |
| Pubmed ID | |
| Authors |
Nazem Bassil, Saad Alkaade, John E Morley |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 19% |
| Canada | 1 | 5% |
| United Kingdom | 1 | 5% |
| Uganda | 1 | 5% |
| Spain | 1 | 5% |
| India | 1 | 5% |
| Unknown | 12 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 62% |
| Practitioners (doctors, other healthcare professionals) | 6 | 29% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 307 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| Italy | 1 | <1% |
| Canada | 1 | <1% |
| United States | 1 | <1% |
| Philippines | 1 | <1% |
| Unknown | 302 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 50 | 16% |
| Student > Master | 41 | 13% |
| Researcher | 40 | 13% |
| Student > Ph. D. Student | 28 | 9% |
| Other | 27 | 9% |
| Other | 59 | 19% |
| Unknown | 62 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 112 | 36% |
| Biochemistry, Genetics and Molecular Biology | 28 | 9% |
| Agricultural and Biological Sciences | 21 | 7% |
| Sports and Recreations | 13 | 4% |
| Psychology | 8 | 3% |
| Other | 53 | 17% |
| Unknown | 72 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 222. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2024.
All research outputs
#176,205
of 25,744,802 outputs
Outputs from Therapeutics and Clinical Risk Management
#8
of 1,323 outputs
Outputs of similar age
#382
of 126,138 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 15 outputs
Altmetric has tracked 25,744,802 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,138 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.